Literature DB >> 28841960

Reply to: "Adjuvant Medications that Improve Survival after Locoregional Therapy".

F Edward Boas1, Etay Ziv1, Hooman Yarmohammadi1, Karen T Brown1, Joseph P Erinjeri1, Constantinos T Sofocleous1, James J Harding2, Stephen B Solomon1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28841960      PMCID： PMC6636677          DOI： 10.1016/j.jvir.2017.06.028

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN： 1051-0443            Impact factor:   3.464


× No keyword cloud information.
  4 in total

1.  Adjuvant Medications That Improve Survival after Locoregional Therapy.

Authors:  F Edward Boas; Etay Ziv; Hooman Yarmohammadi; Karen T Brown; Joseph P Erinjeri; Constantinos T Sofocleous; James J Harding; Stephen B Solomon
Journal:  J Vasc Interv Radiol       Date:  2017-05-17       Impact factor: 3.464

2.  Aspirin in combination with TACE in treatment of unresectable HCC: a matched-pairs analysis.

Authors:  Jing-Huan Li; Yan Wang; Xiao-Ying Xie; Xin Yin; Lan Zhang; Rong-Xin Chen; Zheng-Gang Ren
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

3.  Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma.

Authors:  Vikrant V Sahasrabuddhe; Munira Z Gunja; Barry I Graubard; Britton Trabert; Lauren M Schwartz; Yikyung Park; Albert R Hollenbeck; Neal D Freedman; Katherine A McGlynn
Journal:  J Natl Cancer Inst       Date:  2012-11-28       Impact factor: 13.506

4.  Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

Authors:  Peter M Rothwell; F Gerald R Fowkes; Jill F F Belch; Hisao Ogawa; Charles P Warlow; Tom W Meade
Journal:  Lancet       Date:  2010-12-06       Impact factor: 79.321
  4 in total
  1 in total

1.  Aspirin Is Associated With Improved Liver Function After Embolization of Hepatocellular Carcinoma.

Authors:  F Edward Boas; Karen T Brown; Etay Ziv; Hooman Yarmohammadi; Constantinos T Sofocleous; Joseph P Erinjeri; James J Harding; Stephen B Solomon
Journal:  AJR Am J Roentgenol       Date:  2019-05-23       Impact factor: 3.959
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.